- About Pancreatic Cancer
- Get Support
Caregivers
- Get Involved
- Events
- More
2019-03-01
2022-12
2024-12
300
NCT04211948
Ruijin Hospital
Ruijin Hospital
INTERVENTIONAL
Clinical Study Between Robotic and Open Surgery in Patients With Pancreatic Cancer
The purpose of this study is to determine whether robotic surgery has limitations in terms of patient age, tumor size, location, and vascular relationship when compared to open surgery for pancreatic cancer. Whether robotic surgery has advantages over intraoperative bleeding, operative time, postoperative complications (bleeding, infection, pancreatic fistula) and postoperative hospital stays compared to open surgery.And the differences in lymph nodes harvest and postoperative survival between two groups.
N/A
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
| Study Registration Dates | Results Reporting Dates | Study Record Updates |
|---|---|---|
2019-11-29 | N/A | 2021-04-08 |
2019-12-24 | N/A | 2021-04-09 |
2019-12-26 | N/A | 2021-04 |
This section provides details of the study plan, including how the study is designed and what the study is measuring.
Primary Purpose:
Treatment
Allocation:
Non Randomized
Interventional Model:
Parallel
Masking:
Single
Arms and Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
| EXPERIMENTAL: robotic pancreatectomy robotic pancreatectomy(including pancreaticoduodenectomy and distal pancreatectomy) | PROCEDURE: robotic surgery
|
| ACTIVE_COMPARATOR: open surgery open pancreatectomy(including pancreaticoduodenectomy and distal pancreatectomy) | PROCEDURE: open surgery
|
| Primary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| 1 year overall survival rate | 1 year post-operation | |
| 3 years overall survival rate | 3 years post-operation |
| Secondary Outcome Measures | Measure Description | Time Frame |
|---|---|---|
| Postoperative Complications | pancreatic fistula, bile leakage, hemorrhage, DGE, etc | Within 90 days or before discharge |
| 1, 3years disease free survival rate | 1,3years post-operation |
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
|
Study Contact Name: Kai Qin, Doctor Phone Number: 0086-(0)21-64370045 Email: qinkai310@sina.com |
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.
Ages Eligible for Study:
ALL
Sexes Eligible for Study:
18 Years
Accepts Healthy Volunteers:
This is where you will find people and organizations involved with this study.
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
No publications available
